Raj Mehra

Clinical-stage biopharmaceutical company  Seelos Therapeutics Inc. (Nasdaq: SEEL) entered into a Department of Defense-funded trial to evaluate treatments for post-traumatic stress disorder in military personnel....

Seelos Therapeutics, Inc. (Nasdaq: SEEL) announced top-line data demonstrating clinically meaningful treatment effects across multiple endpoints and a well-tolerated safety profile from the double-blind, placebo-controlled...

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced...

Biopharmaceutical firm Seelos Therapeutics (NASDAQ: SEEL), which develops treatments for central nervous system disorders and rare diseases, has dosed its first patient involved in a...

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced...

Seelos Therapeutics Inc. (Nasdaq: SEEL) announced the completion of enrollment of its registrational Phase II/III trial studying the investigational treatment SLS-005 (trehalose injection, 90.5 mg/mL...

Psychedelics company stock prices have seen some mad swings, especially in the early years when speculation ruled and investors were just taking a shot. Take...

The stock market has been tough over the last month, as has most of the U.S. economy. The Federal Reserve raised interest rates by 0.75...